- Home
- CMPX vs BSII Comparison
CMPX vs BSII Comparison
Compare CMPX & BSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- BSII
- Stock Information
- Founded
- CMPX 2014
- BSII 2024
- Country
- CMPX United States
- BSII Hong Kong
- Employees
- CMPX N/A
- BSII N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- BSII
- Sector
- CMPX Health Care
- BSII
- Exchange
- CMPX Nasdaq
- BSII Nasdaq
- Market Cap
- CMPX 229.5M
- BSII 192.2M
- IPO Year
- CMPX N/A
- BSII 2024
- Fundamental
- Price
- CMPX $1.75
- BSII N/A
- Analyst Decision
- CMPX Strong Buy
- BSII
- Analyst Count
- CMPX 8
- BSII 0
- Target Price
- CMPX $13.38
- BSII N/A
- AVG Volume (30 Days)
- CMPX 2.8M
- BSII 7.2K
- Earning Date
- CMPX 05-12-2025
- BSII 01-01-0001
- Dividend Yield
- CMPX N/A
- BSII N/A
- EPS Growth
- CMPX N/A
- BSII N/A
- EPS
- CMPX N/A
- BSII N/A
- Revenue
- CMPX $850,000.00
- BSII N/A
- Revenue This Year
- CMPX $47.65
- BSII N/A
- Revenue Next Year
- CMPX $2,767.57
- BSII N/A
- P/E Ratio
- CMPX N/A
- BSII $105.03
- Revenue Growth
- CMPX N/A
- BSII N/A
- 52 Week Low
- CMPX $0.77
- BSII $9.85
- 52 Week High
- CMPX $4.08
- BSII $10.35
- Technical
- Relative Strength Index (RSI)
- CMPX 41.42
- BSII N/A
- Support Level
- CMPX $1.60
- BSII N/A
- Resistance Level
- CMPX $1.78
- BSII N/A
- Average True Range (ATR)
- CMPX 0.27
- BSII 0.00
- MACD
- CMPX 0.03
- BSII 0.00
- Stochastic Oscillator
- CMPX 38.01
- BSII 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About BSII Black Spade Acquisition II Co Class A Ordinary Share
Black Spade Acquisition II Co is a blank check company.